1. |
Boeckers TM. The postsynaptic density. Cell Tissue Res 2006; 326:409-22.
|
2. |
Swulius MT, Kubota Y, Forest A, et al. Structure and composition of the postsynaptic density during development. J Comp Neurol 2010; 518:4243-60.
|
3. |
Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 2004, 5:771-81.
|
4. |
Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron 2006; 52:77-92.
|
5. |
Garry EM, Moss A, Delaney A, et al. Neuropathic sensitization of behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions are disrupted in PSD95 mutant mice. Curr Biol 2003; 13:321-8.
|
6. |
Tao F, Tao YX, Mao P, et al. Role of postsynaptic density protein-95 in the maintenance of peripheral nerve in-jury-induced neuropathic pain in rats. Neuroscience 2003; 117:731-9.
|
7. |
Størkson RV, Kjørsvik A, Tjølsen A, et al. Lumbar cathe-terization of the spinal subarachnoid space in the rat. J Neurosci Methods 1996; 65:167-72.
|
8. |
Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33:87-107.
|
9. |
Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10:895-926.
|
10 |
Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci 1987; 7:357-68.
|
11 |
Arundine M, Tymianski M. Molecular mechanisms of cal-cium-dependent neurodegeneration in excitotoxicity. Cell Calcium 2003; 34:325-37.
|
12 |
Beas-Zarate C, Rivera-Huizar SV, Martinez-Contreras A, et al. Changes in NMDA-receptor gene expression are associated with neurotoxicity induced neonatally by glu-tamate in the rat brain. Neurochem Int 2001; 39:1-10.
|
13 |
Sattler R, Xiong Z, Lu WY, et al. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 1999; 284:1845-8.
|
14 |
Wang H, Yu SW, Koh DW, et al. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J Neurosci 2004; 24:10963- 73.
|
15 |
Hou XY, Zhang GY, Wang DG, et al. Suppression of postsynaptic density protein 95 by antisense oligonucleotides diminishes postischemic pyramidal cell death in rat hippocampal CA1 subfield. Neurosci Lett 2005; 385: 230-3.
|
16 |
Petersen JD, Chen X, Vinade L, et al. Distribution of postsynaptic density (PSD)-95 and Ca2+/calmodulinde- pendent protein kinase II at the PSD. J Neurosci 2003; 23:11270-8.
|
17 |
Soderling TR, Chang B, Brickey D. Cellular signaling through multifunctional Ca2+/calmodulin-dependent pro- tein kinase II. J Biol Chem 2001; 276:3719-22.
|
18 |
Shen K, Meyer T. Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science 1999; 284:162-6.
|
19 |
O'Leary H, Liu WH, Rorabaugh JM, et al. Nucleotides and phosphorylation bi-directionally modulate Ca2+/calmo- dulin-dependent protein kinase II (CaMKII) binding to the N-methyl-D-aspartate (NMDA) receptor subunit GluN2B. J Biol Chem 2011; 286:31272-81.
|
20 |
Sanhueza M, Fernandez-Villalobos G, Stein IS, et al. Role of the CaMKII/NMDA receptor complex in the maintenance of synaptic strength. J Neurosci 2011; 31:9170-8.
|
21 |
Fink CC, Meyer T. Molecular mechanisms of CaMKII ac-tivation in neuronal plasticity. Curr Opin Neurobiol 2002; 12:293-9.
|
22 |
Fang L, Wu J, Lin Q, et al. Calcium-calmodulin-dependent protein kinase II contributes to spinal cord central sensi-tization. J Neurosci 2002; 22:4196-204.
|
23 |
Katano T, Nakazawa T, Nakatsuka T, et al. Involvement of spinal phosphorylation cascade of Tyr1472-NR2B,Thr286- CaMKII, and Ser831-GluR1 in neuropathic pain. Neuro-pharmacology 2011; 60:609-16.
|
24 |
Matsumura S, Kunori S, Mabuchi T, et al. Impairment of CaMKII activation and attenuation of neuropathic pain in mice lacking NR2B phosphorylated at Tyr1472. Eur J Neurosci 2010; 32:798-810.
|